Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant

被引:22
作者
Castagnola, E
Machetti, M
Cappelli, B
Molinari, AC
Morreale, G
Dodero, P
Toma, P
Faraci, M
机构
[1] G Gaslini Childrens Hosp, Infect Dis Unit, I-16147 Genoa, Italy
[2] Univ Genoa, Genoa, Italy
[3] Natl Inst Canc Res, Genoa, Italy
[4] G Gaslini Childrens Hosp, Unit Bone Marrow Transplant, Genoa, Italy
[5] G Gaslini Childrens Hosp, Unit Haematol, Genoa, Italy
[6] G Gaslini Childrens Hosp, Surg Unit, Genoa, Italy
[7] G Gaslini Childrens Hosp, Serv Radiol, Genoa, Italy
关键词
amphotericin B; bone marrow transplant; caspofungin; fungal pneumonia; leukaemia; voriconazole;
D O I
10.1111/j.1198-743X.2004.00837.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Caspofungin, in association with other antifungal drugs, was administered as rescue therapy in two cases of documented and one case of possible invasive fungal infection in children with acute leukaemia or undergoing allogeneic bone marrow transplant. The combined therapy was well-tolerated and seemed to be effective in all three patients. A combination antifungal therapy including caspofungin could represent an effective therapy for children with invasive mycoses refractory to single-agent antifungal therapy.
引用
收藏
页码:255 / 257
页数:3
相关论文
共 8 条
[1]   Refractory aspergillus pneumonia in patients with acute leukemia - Successful therapy with combination caspofungin and liposomal amphotericin [J].
Aliff, TB ;
Maslak, PG ;
Jurcic, JG ;
Heaney, ML ;
Cathcart, KN ;
Sepkowitz, KA ;
Weiss, MA .
CANCER, 2003, 97 (04) :1025-1032
[2]   Invasive aspergillosis in allogeneic stem cell transplant recipients: Increasing antigenemia is associated with progressive disease [J].
Boutboul, F ;
Alberti, C ;
Leblanc, T ;
Sulahian, A ;
Gluckman, E ;
Derouin, F ;
Ribaud, P .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (07) :939-943
[3]   Combination therapy with caspofungin and amphotericin B lipid complex [J].
Lum, LR ;
Turco, TF ;
Leone, J .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (01) :80-81
[4]   Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans [J].
Rubin, MA ;
Carroll, KC ;
Cahill, BC .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (08) :1160-1161
[5]   Progressive cutaneous hyalohyphomycosis due to Paecilomyces lilacinus:: Rapid response to treatment with caspofungin and Itraconazole [J].
Safdar, A .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (10) :1415-1417
[6]   Trends in the epidemiology of opportunistic fungal infections: Predisposing factors and the impact of antimicrobial use practices [J].
Singh, N .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (10) :1692-1696
[7]   Practice guidelines for diseases caused by Aspergillus [J].
Stevens, DA ;
Kan, VL ;
Judson, MA ;
Morrison, VA ;
Dummer, S ;
Denning, DW ;
Bennett, JE ;
Walsh, TJ ;
Patterson, TF ;
Pankey, GA .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (04) :696-709
[8]  
WALSH TJ, 2002, 42 INT C ANT AG CHEM, P395